| __timestamp | Amneal Pharmaceuticals, Inc. | Ligand Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 335989000 | 9136000 |
| Thursday, January 1, 2015 | 367054000 | 5807000 |
| Friday, January 1, 2016 | 420770000 | 5571000 |
| Sunday, January 1, 2017 | 507476000 | 5366000 |
| Monday, January 1, 2018 | 946588000 | 6337000 |
| Tuesday, January 1, 2019 | 1273376000 | 11347000 |
| Wednesday, January 1, 2020 | 1364130000 | 30419000 |
| Friday, January 1, 2021 | 1324696000 | 62176000 |
| Saturday, January 1, 2022 | 1427596000 | 52827000 |
| Sunday, January 1, 2023 | 1573042000 | 35049000 |
Unlocking the unknown
In the ever-evolving pharmaceutical industry, understanding cost dynamics is crucial. Amneal Pharmaceuticals, Inc. and Ligand Pharmaceuticals Incorporated present a fascinating case study. From 2014 to 2023, Amneal's cost of revenue surged by approximately 368%, reflecting its aggressive expansion and market penetration strategies. In contrast, Ligand's cost of revenue, while significantly lower, increased by around 283%, indicating a more conservative growth approach.
Amneal's cost of revenue peaked in 2023, reaching nearly 1.57 billion, a testament to its robust operational scale. Meanwhile, Ligand's cost of revenue, though modest, saw its highest point in 2021, at about 62 million, before slightly declining. This divergence highlights the distinct business models and market strategies of these two companies.
As the pharmaceutical landscape continues to shift, these insights offer a window into the strategic decisions shaping the industry's future.
Novo Nordisk A/S vs Ligand Pharmaceuticals Incorporated: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: AbbVie Inc. vs Amneal Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Pfizer Inc. vs Ligand Pharmaceuticals Incorporated
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Amneal Pharmaceuticals, Inc.
Cost of Revenue Comparison: Neurocrine Biosciences, Inc. vs Amneal Pharmaceuticals, Inc.
Analyzing Cost of Revenue: Insmed Incorporated and Amneal Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: BioMarin Pharmaceutical Inc. vs Amneal Pharmaceuticals, Inc.
Walgreens Boots Alliance, Inc. vs Ligand Pharmaceuticals Incorporated: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Cytokinetics, Incorporated vs Amneal Pharmaceuticals, Inc.
Cost Insights: Breaking Down Ionis Pharmaceuticals, Inc. and Amneal Pharmaceuticals, Inc.'s Expenses
Cost of Revenue Comparison: Amneal Pharmaceuticals, Inc. vs Xencor, Inc.
Analyzing Cost of Revenue: Veracyte, Inc. and Ligand Pharmaceuticals Incorporated